AIDS Crisis Calls for 'Firm Leadership and Direction'

Q: The AIDS report is a major example of IOM’s increased visibility. Its recommendations have been widely disseminated. Are you happy with the response it’s gotten from policymakers? THIER: The response from the research community has been pretty reasonable. The major concern is that we pointed out that education is our only major intervention until therapies and vaccines are developed, but the amount of activity relating to education has been very modest. We also were concerned th

Written byTabitha M. Powledge
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Q: The AIDS report is a major example of IOM’s increased visibility. Its recommendations have been widely disseminated. Are you happy with the response it’s gotten from policymakers?

THIER: The response from the research community has been pretty reasonable. The major concern is that we pointed out that education is our only major intervention until therapies and vaccines are developed, but the amount of activity relating to education has been very modest. We also were concerned that if you conceptualize AIDS only in the medical model, without seeing the social and international implications, it would be very hard to get a sound national response.

We also pointed to the need for some kind of a coordinating mechanism. We’re facing a rather serious problem in which the numbers at the moment don’t reflect what’s coming at us, and where, if we act, we could do something to trim off a rapid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies